Europe Antibiotics Market Size, Share & Trends Report

Europe Antibiotics Market (2024 - 2030) Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin), By Type (Branded Antibodies, Generic Antibodies), By Action Mechanism, By Country, And Segment Forecasts

Market Segmentation

Europe Antibiotics Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Cephalosporin
- Penicillin
- Fluoroquinolone
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
- 7-ACA
- Others
Europe Antibiotics Type Outlook (Revenue, USD Million, 2018 - 2030)
- Branded Antibiotics
- Generic Antibiotics
Europe Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2018 - 2030)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
Europe Antibiotics Country Outlook (Revenue, USD Million, 2018 - 2030)
- Europe
  - Europe Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolides
    - Carbapenems
    - Aminoglycosides
    - Sulfonamides
    - 7-ACA
    - Others
  - Europe Antibiotics Market, By Type
    - Branded Antibiotics
    - Generic Antibiotics
  - Europe Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - Germany
    - Germany Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolides
      - Carbapenems
      - Aminoglycosides
      - Sulfonamides
      - 7-ACA
      - Others
    - Germany Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Germany Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - UK
    - UK Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolides
      - Carbapenems
      - Aminoglycosides
      - Sulfonamides
      - 7-ACA
      - Others
    - UK Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - UK Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - France
    - France Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolides
      - Carbapenems
      - Aminoglycosides
      - Sulfonamides
      - 7-ACA
      - Others
    - France Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - France Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Italy
    - Italy Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolides
      - Carbapenems
      - Aminoglycosides
      - Sulfonamides
      - 7-ACA
      - Others
    - Italy Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Italy Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Spain
    - Spain Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolides
      - Carbapenems
      - Aminoglycosides
      - Sulfonamides
      - 7-ACA
      - Others
    - Spain Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Spain Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Denmark
    - Denmark Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolides
      - Carbapenems
      - Aminoglycosides
      - Sulfonamides
      - 7-ACA
      - Others
    - Denmark Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Denmark Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Sweden
    - Sweden Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolides
      - Carbapenems
      - Aminoglycosides
      - Sulfonamides
      - 7-ACA
      - Others
    - Sweden Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Sweden Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Norway
    - Norway Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolides
      - Carbapenems
      - Aminoglycosides
      - Sulfonamides
      - 7-ACA
      - Others
    - Norway Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Norway Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments